Lindbrook Capital, LLC Forte Biosciences, Inc. Transaction History

Lindbrook Capital, LLC

  • $1.18 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 05, 2021
SELL
$2.96 - $36.67 $4,440 - $55,005
-1,500 Closed
0 $0
Q2 2021

Jul 27, 2021
BUY
$31.5 - $42.5 $15,750 - $21,250
500 Added 50.0%
1,500 $50,000
Q1 2021

Apr 28, 2021
BUY
$25.01 - $40.24 $25,010 - $40,240
1,000 New
1,000 $34,000

Others Institutions Holding FBRX

# of Institutions
1
Shares Held
175K
Call Options Held
0
Put Options Held
0
View Full List

About Forte Biosciences, Inc.

FBRX Quotes by TradingView
  • Ticker FBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,340,300
  • Market Cap $371M
  • Description
  • Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
More about FBRX
Track This Portfolio

Track Lindbrook Capital, LLC Portfolio

Follow Lindbrook Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email